A meta-analysis involving 8583 breast cancer patients of various subtypes suggested that PD-L1 overexpression is significantly negatively correlated with the overall survival of patients, and the mechanism may be that high PD-L1 expression promotes breast cancer immune escape [4]. Here, CD274 is linked to breast carcinoma.